Raymond James & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $895M | Buy |
|
|||||
|
2024
Q2 | $773M | Buy |
|
|||||
|
2024
Q1 | $787M | Sell |
|
|||||
|
2023
Q4 | $699M | Buy |
|
|||||
|
2023
Q3 | $660M | Buy |
|
|||||
|
2023
Q2 | $584M | Sell |
|
|||||
|
2023
Q1 | $741M | Buy |
|
|||||
|
2022
Q4 | $726M | Buy |
|
|||||
|
2022
Q3 | $532M | Buy |
|
|||||
|
2022
Q2 | $581M | Sell |
|
|||||
|
2022
Q1 | $672M | Buy |
|
|||||
|
2021
Q4 | $548M | Buy |
|
|||||
|
2021
Q3 | $427M | Buy |
|
|||||
|
2021
Q2 | $422M | Buy |
|
|||||
|
2021
Q1 | $387M | Sell |
|
|||||
|
2020
Q4 | $386M | Buy |
|
|||||
|
2020
Q3 | $284M | Sell |
|
|||||
|
2020
Q2 | $323M | Buy |
|
|||||
|
2020
Q1 | $243M | Buy |
|
|||||
|
2019
Q4 | $280M | Buy |
|
|||||
|
2019
Q3 | $231M | Buy |
|
|||||
|
2019
Q2 | $195M | Sell |
|
|||||
|
2019
Q1 | $353M | Buy |
|
|||||
|
2018
Q4 | $369M | Buy |
|
|||||
|
2018
Q3 | $334M | Buy |
|
|||||
|
2018
Q2 | $315M | Buy |
|
|||||
|
2018
Q1 | $312M | Sell |
|
|||||
|
2017
Q4 | $378M | Sell |
|
|||||
|
2017
Q3 | $395M | Sell |
|
|||||
|
2017
Q2 | $377M | Buy |
|
|||||
|
2017
Q1 | $307M | Buy |
|
|||||
|
2016
Q4 | $243M | Buy |
|
|||||
|
2016
Q3 | $188M | Buy |
|
|||||
|
2016
Q2 | $132M | Buy |
|
|||||
|
2016
Q1 | $116M | Buy |
|
|||||
|
2015
Q4 | $59.3M | Buy |
|
|||||
|
2015
Q3 | $44.7M | Buy |
|
|||||
|
2015
Q2 | $47.3M | Sell |
|
|||||
|
2015
Q1 | $52.3M | Buy |
|
|||||
|
2014
Q4 | $52.2M | Buy |
|
|||||
|
2014
Q3 | $38.7M | Sell |
|
|||||
|
2014
Q2 | $43.2M | Buy |
|
|||||
|
2014
Q1 | $37.1M | Sell |
|
|||||
|
2013
Q4 | $48.9M | Buy |
|
|||||
|
2013
Q3 | $37M | Sell |
|
|||||
|
2013
Q2 | $34.6M | Buy |
|